Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

SLR Investment Corp reports Q1 2026 net investment income of $0.33/share and stable $18.16 NAV, declares $0.31 dividend.

Company Fundamentals
05 May 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

SLR Investment Corp announced its financial results for Q1 2026, reporting net investment income of $17.9 million or $0.33 per share, with a net asset value (NAV) of $18.16 per share, slightly down from $18.26 at year-end 2025. The company declared a quarterly dividend of $0.31 per share payable in June 2026. Despite geopolitical and market uncertainties, SLR maintained a 100% performing portfolio and reduced its performance-based incentive fee to align with shareholders. The company remains cautious but optimistic about rebuilding its portfolio and pursuing growth initiatives in specialty finance sectors throughout the year.

More News

Navios Maritime rated Buy on strong earnings, fleet growth, and 56% NAV discount offering upside.

Navios Maritime rated Buy on strong earnings, fleet growth, and 56% NAV discount offering upside.

Navios Maritime (NMM) is rated Buy due to its strong earnings, organic growth, and a significant 56% discount to net asset value (NAV). The company operates a diversified fleet of 149 vessels across dry bulk, containerships, and tankers, maintaining ...

Analyst Insights
Bullish
4 hours ago
Investigation launched over Regeneron’s optimistic trial claims that preceded stock drop.

Investigation launched over Regeneron’s optimistic trial claims that preceded stock drop.

Levi & Korsinsky has started an investigation into Regeneron Pharmaceuticals for potentially misleading investors about the results of a clinical trial. In March 2026, Regeneron's investor relations VP expressed hope for positive trial outcomes of a ...

Market News
Bearish
4 hours ago
Investigation launched into Prestige Consumer Healthcare over missed earnings and undisclosed acquisition

Investigation launched into Prestige Consumer Healthcare over missed earnings and undisclosed acquisition

Levi & Korsinsky has started an investigation into Prestige Consumer Healthcare following the company's failure to meet its Q4 and full-year financial projections, including adjusted gross margin, free cash flow, and adjusted EPS. Additionally, Prest...

Market News
Bearish
4 hours ago
Investigation launched into TriSalus Life Sciences after Q1 revenue misses estimates and cuts full-year guidance

Investigation launched into TriSalus Life Sciences after Q1 revenue misses estimates and cuts full-year guidance

Levi & Korsinsky has started an investigation into TriSalus Life Sciences following the company's Q1 2026 revenue of $8.9 million, which missed Wall Street's $9.4 million estimate. The company also lowered its full-year 2026 revenue forecast to $54 m...

Market News
Bearish
4 hours ago
Bitcoin whale traders increase short bets amid weakening crypto momentum and rising market caution.

Bitcoin whale traders increase short bets amid weakening crypto momentum and rising market caution.

Bitcoin whale traders have shifted aggressively toward short positions, reflecting growing defensive sentiment amid weakening broader crypto momentum. Large speculative wallets reduced altcoin exposure and increased leveraged Bitcoin shorts, with one...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App